INS and obesity due to melanocortin 4 receptor deficiency: The result is the impairment of insulin actions and glucose utility in the liver, skeletal muscles, and adipose tissues with a series of metabolic abnormalities, and the eventual development of obesity-associated complications [11,12,13,14,15,16,17].